Navigation Links
GranuFlo Lawsuits Mount, as Filings in Federal GranuFlo Recall Litigation Approach 400, Bernstein Liebhard LLP Reports
Date:11/19/2013

New York, NY (PRWEB) November 19, 2013

GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) stemming from the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, the number of claims pending against Fresenius Medical Care in the multidistrict litigation underway in U.S. District Court, District of Massachusetts, is approaching 400, with at least 393 dialysis lawsuits involving GranuFlo and NaturaLyte filed so far. The Court’s previous update issued in October indicated that just over 300 GranuFlo recall claims had been filed in the proceeding at that time. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“We continue to hear from dialysis patients, as well as their families, who allegedly suffered side effects related to the GranuFlo recall. It’s not surprising that the number of dialysis lawsuits pending against Fresenius has grown at this rate,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free GranuFlo lawsuit evaluations to dialysis patients who suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects allegedly related to the administration of GranuFlo and NaturaLyte during dialysis treatments.

GranuFlo Recall
GranuFlo and NaturaLyte, which are used during dialysis to remove acid from the blood, were named in a Class I recall in 2012, after inappropriate dosing of the products was linked to dangerously high levels of bicarbonate in patients’ blood. According to the U.S. Food & Drug Administration (FDA), this can result in a condition called metabolic alkalosis, which may cause dialysis patients to suffer heart attacks strokes, sudden cardiac death and other catastrophic heart problems following administration of the drugs. Fresenius first warned dialysis clinics of this potential danger associated with GranuFlo and NaturaLyte via an Urgent Product Notification issued in March 2012. The notification was then granted Class I recall status by the FDA, which according to the agency, indicates the products are associated with a significant risk of serious injury and death.

According to a recent report from The New York Times, the FDA also launched an investigation of Fresenius’ handling of the GranuFlo recall, after it became aware that the company had notified dialysis clinics within its own network of these issues via a memo it circulated in November 2011. The FDA is trying to determine if the company’s delay between the November 2011 memo and the March 2012 notification to dialysis clinics nationwide violated any federal regulations.*

According to court documents, the GranuFlo lawsuits pending in Massachusetts federal court involve similar allegations that Fresenius Medical Care failed to provide adequate warnings regarding the use of GranuFlo and NaturaLyte, and continued to aggressively market both products after their risks became apparent in order to protect their market share. In addition to the federal proceeding, court records show that scores of similar dialysis lawsuits involving GranuFlo and NaturaLyte have also been filed in in Massachusetts’ Middlesex County Superior Court. Bernstein Liebhard LLP is actively filing claims in that proceeding. (In re Consolidated Fresenius Cases, No. MICV2013-03400-O)

Dialysis patients or the families of patients who allegedly suffered a heart attack, stroke, sudden cardiac death or other catastrophic heart event within 72 hours of administration of GranuFlo or NaturaLyte may be eligible to file a dialysis lawsuit against Fresenius Medical Care. Learn More about the GranuFlo recall at Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/dialysis-lawsuit/prweb11348640.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal GranuFlo Recall Litigation
2. New GranuFlo Lawsuit Website from Bernstein Liebhard LLP Provides Vital Dialysis Recall Information, Instructions on Filing a Claim
3. Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
4. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
5. GranuFlo Lawsuits Mount, as Bernstein Liebhard LLP Notes New Consolidated Litigation for GranuFlo Recall Claims Filed in Massachusetts State Court
6. GranuFlo Lawsuit News: Bernstein Liebhard LLP Comments on Fresenius FDA Warning Letter, as GranuFlo Recall Claims Mount
7. GranuFlo Lawsuits News: Calif. Lawsuit Alleges Drug Maker Hid Serious Health Risks, Rottenstein Law Group LLP Reports
8. 201 Actions Pending in the Granuflo Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
9. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
10. NaturaLyte and GranuFlo Lawsuits Are Heating Up
11. New Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: Resource4thePeople Reports Important Hearing Is Scheduled in Fresenius Multidistrict Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Delaware farmer Rick Dickerson attended ... Missouri. , Dickerson, of Laurel, farms about a thousand acres of soybeans, corn and ... on contract and pumpkins and other vegetables for the fresh market. He also operates ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... publication among specialty pharmacists and pharmacy professionals, has teamed up with Ochsner ... (SAP) program, announced Brian Haug, president of Pharmacy Healthcare Communications, LLC, publishers ...
(Date:1/18/2017)... ... January 18, 2017 , ... Park Agencies Insurance & ... to families and business owners in the greater Kansas City area, is joining ... disabilities. , The Lakemary Center is a comprehensive educational resource center that provides ...
(Date:1/18/2017)... ... 2017 , ... The Hear the World Foundation, a Sonova ... of cochlear implants. In February 2017, the first three children with profound hearing ... leading an independent life. This engagement builds on the support the Hear the ...
(Date:1/17/2017)... ... 17, 2017 , ... Anesthesia Progress – Everyone wants less pain ... drug option for each patient. Dentists have several general anesthesia alternatives and finding the ... from the Tokyo Dental College in Tokyo, Japan wanted to find out which anesthetic ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... BETHESDA, Md. , Jan. 18, 2017 /PRNewswire/ ... in the coffee family, are often used to ... are consumed by several million Americans annually to ... as a natural remedy for minor aches and ... kratom,s effects is intended to assist FDA and ...
(Date:1/18/2017)... Suiza, 18 de enero de 2017  Hoy, en ... Access Accelerated, una iniciativa global para avanzar el acceso ... atención en países de renta baja y baja-media (LICs ... un punto de crisis, particularmente en países de renta ... por ciento de las muertes relacionadas con NCD. El ...
(Date:1/18/2017)... In China , we say ... Upgrade of China,s Healthy Strategy originates. ... for Economic and Social Development of the People,s ... the state council of the People,s Republic of ... industry development plan, identifying medical devices as one of the ...
Breaking Medicine Technology: